BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11753986)

  • 1. Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1alpha and epidermal growth factor.
    Chen Z; Fadiel A; Feng Y; Ohtani K; Rutherford T; Naftolin F
    Cancer; 2001 Dec; 92(12):3068-75. PubMed ID: 11753986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezrin overexpression by transformed human ovarian surface epithelial cells, ovarian cleft cells, and serous ovarian adenocarcinoma cells.
    Fadiel A; Chen Z; Ulukus E; Ohtani K; Hatami M; Naftolin F
    Reprod Sci; 2012 Aug; 19(8):797-805. PubMed ID: 22477337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
    Ellerbroek SM; Hudson LG; Stack MS
    Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezrin Promotes the Proliferation, Migration, and Invasion of Ovarian Cancer Cells.
    Li MJ; Xiong D; Huang H; Wen ZY
    Biomed Environ Sci; 2021 Feb; 34(2):139-151. PubMed ID: 33685573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
    Vacca F; Bagnato A; Catt KJ; Tecce R
    Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tyrosine phosphorylation and translocation of ezrin by hepatocyte growth factor/scatter factor.
    Jiang WG; Hiscox S; Singhrao SK; Puntis MC; Nakamura T; Mansel RE; Hallett MB
    Biochem Biophys Res Commun; 1995 Dec; 217(3):1062-9. PubMed ID: 8554558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor.
    Bretscher A
    J Cell Biol; 1989 Mar; 108(3):921-30. PubMed ID: 2646308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol-induced ezrin overexpression in ovarian cancer: a new signaling domain for estrogen.
    Song J; Fadiel A; Edusa V; Chen Z; So J; Sakamoto H; Fishman DA; Naftolin F
    Cancer Lett; 2005 Mar; 220(1):57-65. PubMed ID: 15737688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells.
    Mak H; Naba A; Varma S; Schick C; Day A; SenGupta SK; Arpin M; Elliott BE
    BMC Cancer; 2012 Mar; 12():82. PubMed ID: 22397367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells.
    Syed V; Ulinski G; Mok SC; Ho SM
    J Natl Cancer Inst; 2002 Apr; 94(8):617-29. PubMed ID: 11959895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezrin/NF-κB Pathway Regulates EGF-induced Epithelial-Mesenchymal Transition (EMT), Metastasis, and Progression of Osteosarcoma.
    Liu P; Yang P; Zhang Z; Liu M; Hu S
    Med Sci Monit; 2018 Apr; 24():2098-2108. PubMed ID: 29628496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [p120(ctn) tyrosine phosphorylation are involved in the biologic behavior changes of hepatocellular carcinoma cells].
    Huang HY; Nong CZ; Guo LX; Xu Z; Zha XL
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1801-6. PubMed ID: 14642088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.
    Colomiere M; Ward AC; Riley C; Trenerry MK; Cameron-Smith D; Findlay J; Ackland L; Ahmed N
    Br J Cancer; 2009 Jan; 100(1):134-44. PubMed ID: 19088723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezrin/NF-kB activation regulates epithelial- mesenchymal transition induced by EGF and promotes metastasis of colorectal cancer.
    Li Y; Lin Z; Chen B; Chen S; Jiang Z; Zhou T; Hou Z; Wang Y
    Biomed Pharmacother; 2017 Aug; 92():140-148. PubMed ID: 28535417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells.
    Wang Y; Li L; Guo X; Jin X; Sun W; Zhang X; Xu RC
    Cytokine; 2012 Aug; 59(2):228-36. PubMed ID: 22595649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
    Gründker C; Völker P; Emons G
    Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the two major epidermal growth factor-induced tyrosine phosphorylation sites in the microvillar core protein ezrin.
    Krieg J; Hunter T
    J Biol Chem; 1992 Sep; 267(27):19258-65. PubMed ID: 1382070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Ho SM; Lau KM; Mok SC; Syed V
    Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma.
    Köbel M; Gradhand E; Zeng K; Schmitt WD; Kriese K; Lantzsch T; Wolters M; Dittmer J; Strauss HG; Thomssen C; Hauptmann S
    Int J Gynecol Pathol; 2006 Apr; 25(2):121-30. PubMed ID: 16633060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.